Related Experiment Video
Updated: Jun 16, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Prevalence and predictors of coeliac disease in patients with irritable bowel syndrome: A prospective study from
Dholavan Mayur1, Ankit Agarwal2, Chhagan Lal Birda2
1Department of Internal medicine, All India Institute of Medical Sciences, Jodhpur, India.
Abstract:
Our study aims to assess the prevalence of coeliac disease (CD) among patients with irritable bowel syndrome (IBS), a recognised high-risk group for CD, in Rajasthan. We found 9/287 consecutive adult IBS patients seropositive or with biopsy-confirmed CD. Lower haemoglobin levels were independently associated with CD.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome
Inflammatory Bowel Disease IV: Clinical Manifestations
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
